The Unified Patent Court (UPC) recently revoked a Sanofi-Aventis patent against Amgen, just 13 months after the case started. This quick decision underscores the need for patentees to consider their European validation strategies carefully.Many US patentees don't realize that national parts of a...
Sign up for our newsletter
